|
Originally published In Press as doi:10.1074/jbc.M611705200 on March 30, 2007
J. Biol. Chem., Vol. 282, Issue 21, 15528-15533, May 25, 2007
Selective Amino Acid Substitutions Convert the Creatine Transporter to a -Aminobutyric Acid Transporter*
Joanna R. Dodd and
David L. Christie1
From the
Molecular, Cellular, and Developmental Biology Section, School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand
The creatine transporter (CRT) is a member of a large family of sodium-dependent neurotransmitter and amino acid transporters. The CRT is closely related to the -aminobutyric acid (GABA) transporter, GAT-1, yet GABA is not an effective substrate for the CRT. The high resolution structure of a prokaryotic homologue, LeuT has revealed precise details of the substrate binding site for leucine (Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., and Gouaux, E. (2005) Nature 437, 215-223). We have now designed mutations based on sequence comparisons of the CRT with GABA transporters and the LeuT structural template in an attempt to alter the substrate specificity of the CRT. Combinations of two or three amino acid substitutions at four selected positions resulted in the loss of creatine transport activity and gain of a specific GABA transport function. GABA transport by the "gain of function" mutants was sensitive to nipecotic acid, a competitive inhibitor of GABA transporters. Our results show LeuT to be a good structural model to identify amino acid residues involved in the substrate and inhibitor selectivity of eukaryotic sodium-dependent neurotransmitter and amino acid transporters. However, modification of the binding site alone appears to be insufficient for efficient substrate translocation. Additional residues must mediate the conformational changes required for the diffusion of substrate from the binding site to the cytoplasm.
Received for publication, December 21, 2006
, and in revised form, March 29, 2007.
* This research was supported by grants from the Maurice and Phyllis Paykel Trust, the Neurological Foundation of New Zealand, and the Auckland Medical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Molecular, Cellular, and Developmental Biology Section, School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand. Tel.: 64-9-3737-599; Fax: 64-9-3737-414; E-mail: d.christie{at}auckland.ac.nz.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Ben-Yona and B. I. Kanner
Transmembrane Domain 8 of the {gamma}-Aminobutyric Acid Transporter GAT-1 Lines a Cytoplasmic Accessibility Pathway into Its Binding Pocket
J. Biol. Chem.,
April 10, 2009;
284(15):
9727 - 9732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Andersen, O. Taboureau, K. B. Hansen, L. Olsen, J. Egebjerg, K. Stromgaard, and A. S. Kristensen
Location of the Antidepressant Binding Site in the Serotonin Transporter: IMPORTANCE OF SER-438 IN RECOGNITION OF CITALOPRAM AND TRICYCLIC ANTIDEPRESSANTS
J. Biol. Chem.,
April 10, 2009;
284(15):
10276 - 10284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rosenberg and B. I. Kanner
The Substrates of the {gamma}-Aminobutyric Acid Transporter GAT-1 Induce Structural Rearrangements around the Interface of Transmembrane Domains 1 and 6
J. Biol. Chem.,
May 23, 2008;
283(21):
14376 - 14383.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|